197 related articles for article (PubMed ID: 10454092)
21. MT3-MMP (MMP-16) is downregulated by in vitro cytokine stimulation of cartilage, but unaltered in naturally occurring equine osteoarthritis and osteochondrosis.
Garvican ER; Vaughan-Thomas A; Redmond C; Clegg PD
Connect Tissue Res; 2008; 49(2):62-7. PubMed ID: 18382891
[TBL] [Abstract][Full Text] [Related]
22. Endogenous MMP-9 and not MMP-2 promotes rheumatoid synovial fibroblast survival, inflammation and cartilage degradation.
Xue M; McKelvey K; Shen K; Minhas N; March L; Park SY; Jackson CJ
Rheumatology (Oxford); 2014 Dec; 53(12):2270-9. PubMed ID: 24982240
[TBL] [Abstract][Full Text] [Related]
23. Galectin-1 and galectin-3 expression in equine mesenchymal stromal cells (MSCs), synovial fibroblasts and chondrocytes, and the effect of inflammation on MSC motility.
Reesink HL; Sutton RM; Shurer CR; Peterson RP; Tan JS; Su J; Paszek MJ; Nixon AJ
Stem Cell Res Ther; 2017 Nov; 8(1):243. PubMed ID: 29096716
[TBL] [Abstract][Full Text] [Related]
24. Microscopic localization of active gelatinases in equine osteochondritis dissecans (OCD) cartilage.
Al-Hizab F; Clegg PD; Thompson CC; Carter SD
Osteoarthritis Cartilage; 2002 Aug; 10(8):653-61. PubMed ID: 12479388
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of interleukin-1beta-stimulated production of matrix metalloproteinases by hyaluronan via CD44 in human articular cartilage.
Julovi SM; Yasuda T; Shimizu M; Hiramitsu T; Nakamura T
Arthritis Rheum; 2004 Feb; 50(2):516-25. PubMed ID: 14872494
[TBL] [Abstract][Full Text] [Related]
26. Phase 2 enzyme inducer sulphoraphane blocks matrix metalloproteinase production in articular chondrocytes.
Kim HA; Yeo Y; Kim WU; Kim S
Rheumatology (Oxford); 2009 Aug; 48(8):932-8. PubMed ID: 19491303
[TBL] [Abstract][Full Text] [Related]
27. Effect of glucosamine on interleukin-1-conditioned articular cartilage.
Fenton JI; Chlebek-Brown KA; Caron JP; Orth MW
Equine Vet J Suppl; 2002 Sep; (34):219-23. PubMed ID: 12405690
[TBL] [Abstract][Full Text] [Related]
28. Cytokine and catabolic enzyme expression in synovium, synovial fluid and articular cartilage of naturally osteoarthritic equine carpi.
Kamm JL; Nixon AJ; Witte TH
Equine Vet J; 2010 Nov; 42(8):693-9. PubMed ID: 21039798
[TBL] [Abstract][Full Text] [Related]
29. The fibronectin extra domain A activates matrix metalloproteinase gene expression by an interleukin-1-dependent mechanism.
Saito S; Yamaji N; Yasunaga K; Saito T; Matsumoto S; Katoh M; Kobayashi S; Masuho Y
J Biol Chem; 1999 Oct; 274(43):30756-63. PubMed ID: 10521465
[TBL] [Abstract][Full Text] [Related]
30. Measurement of cartilage oligomeric matrix protein (COMP) in normal and diseased equine synovial fluids.
Misumi K; Vilim V; Clegg PD; Thompson CC; Carter SD
Osteoarthritis Cartilage; 2001 Feb; 9(2):119-27. PubMed ID: 11237659
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the influence of prostaglandin E2 on recombinant equine interleukin-1beta-stimulated matrix metalloproteinases 1, 3, and 13 and tissue inhibitor of matrix metalloproteinase 1 expression in equine chondrocyte cultures.
Tung JT; Arnold CE; Alexander LH; Yuzbasiyan-Gurkan V; Venta PJ; Richardson DW; Caron JP
Am J Vet Res; 2002 Jul; 63(7):987-93. PubMed ID: 12118680
[TBL] [Abstract][Full Text] [Related]
32. Expression of membrane-type 1 matrix metalloproteinase in rheumatoid synovial cells.
Honda S; Migita K; Hirai Y; Origuchi T; Yamasaki S; Kamachi M; Shibatomi K; Fukuda T; Kita M; Hida A; Ida H; Aoyagi T; Kawakami A; Kawabe Y; Oizumi K; Eguchi K
Clin Exp Immunol; 2001 Oct; 126(1):131-6. PubMed ID: 11678909
[TBL] [Abstract][Full Text] [Related]
33. Cyclosporin A inhibition of aggrecanase-mediated proteoglycan catabolism in articular cartilage.
Little CB; Hughes CE; Curtis CL; Jones SA; Caterson B; Flannery CR
Arthritis Rheum; 2002 Jan; 46(1):124-9. PubMed ID: 11817583
[TBL] [Abstract][Full Text] [Related]
34. Activation of cartilage matrix metalloproteinases by activated protein C.
Jackson MT; Smith MM; Smith SM; Jackson CJ; Xue M; Little CB
Arthritis Rheum; 2009 Mar; 60(3):780-91. PubMed ID: 19248107
[TBL] [Abstract][Full Text] [Related]
35. Collagenase-1 (MMP-1) activity in equine synovial fluid: influence of age, joint pathology, exercise and repeated arthrocentesis.
Brama PA; van den Boom R; DeGroott J; Kiers GH; van Weeren PR
Equine Vet J; 2004 Jan; 36(1):34-40. PubMed ID: 14756369
[TBL] [Abstract][Full Text] [Related]
36. In vitro evidence for a bacterial pathogenesis of equine laminitis.
Mungall BA; Kyaw-Tanner M; Pollitt CC
Vet Microbiol; 2001 Apr; 79(3):209-23. PubMed ID: 11240100
[TBL] [Abstract][Full Text] [Related]
37. Spontaneous production of nitric oxide (NO), prostaglandin (PGE2) and neutral metalloproteinases (NMPs) in media of explant cultures of equine synovial membrane and articular cartilage from normal and osteoarthritic joints.
von Rechenberg B; McIlwraith CW; Akens MK; Frisbie DD; Leutenegger C; Auer JA
Equine Vet J; 2000 Mar; 32(2):140-50. PubMed ID: 10743970
[TBL] [Abstract][Full Text] [Related]
38. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) is induced in rabbit articular chondrocytes by cotreatment with interleukin 1 beta and a protein kinase C activator.
Ogata Y; Pratta MA; Nagase H; Arner EC
Exp Cell Res; 1992 Aug; 201(2):245-9. PubMed ID: 1322311
[TBL] [Abstract][Full Text] [Related]
39. MMP-mediated collagen breakdown induced by activated protein C in equine cartilage is reduced by corticosteroids.
Garvican ER; Vaughan-Thomas A; Redmond C; Gabriel N; Clegg PD
J Orthop Res; 2010 Mar; 28(3):370-8. PubMed ID: 19777546
[TBL] [Abstract][Full Text] [Related]
40. MMP-9 mediated Syndecan-4 shedding correlates with osteoarthritis severity.
Bollmann M; Pinno K; Ehnold LI; Märtens N; Märtson A; Pap T; Stärke C; Lohmann CH; Bertrand J
Osteoarthritis Cartilage; 2021 Feb; 29(2):280-289. PubMed ID: 33246160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
